Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin.

Pediatric blood & cancer - 1 Jul 2009

Watt Tanya, Warshaw Barry, Katzenstein Howard M

Abstract excerpt

Atypical hemolytic uremic syndrome remains a challenge to diagnose and treat, with significant acute morbidity and risk for progression to end stage renal disease. Treatment strategies center on plasma exchange but do not necessarily affect the progression of disease. We report the case of a pati...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Transfusion
Share to Glucocorticoids
Share to Hemolytic-Uremic Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulins, Intravenous

Share to Immunologic Factors

Share to Membrane Cofactor Protein

Share to Methylprednisolone

Share to Treatment Outcome

Source

Identifiers

PMID: 19301397
DOI: 10.1002/pbc.21951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19301397-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin.PMID 19301397Read ↗

Atypical Hemolytic Uremic SyndromeSemantic proximity Read ↗

Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy.Semantic proximity Read ↗

A time for reappraisal of "atypical" hemolytic uremic syndrome: should all patients be treated the same?Semantic proximity Read ↗

How I diagnose and treat atypical hemolytic uremic syndromeSemantic proximity Read ↗

New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.Semantic proximity Read ↗

Haemolytic uraemic syndrome.Semantic proximity Read ↗

Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.Semantic proximity Read ↗

[Atypical hemolytic uremic syndrome].Semantic proximity Read ↗

Atypical hemolytic uremic syndrome: update on the complement system and what is new.Semantic proximity Read ↗

A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.